Qun Wang1, Jianguang Du1, Jingjing Zhu1, Xiaowei Yang2, Baohua Zhou3. 1. Department of Pediatrics, HB Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Ind. 2. Department of Veterinary Medicine, Southwest University at Rongchang, Chongqing, China. 3. Department of Pediatrics, HB Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Ind; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Ind. Electronic address: zhoub@iu.edu.
Abstract
BACKGROUND: Thymic stromal lymphopoietin (TSLP) is a key factor in the development of allergic asthma. Numbers of TH2 memory cells gradually increase in allergic patients with the progression of disease and persist in the lungs during remission, although the mechanism is not clear. OBJECTIVE: We sought to define the role of TSLP in TH2 memory cell generation and maintenance in vivo. METHODS: Adoptive transfer of wild-type and thymic stromal lymphopoietin receptor (TSLPR)-deficient ovalbumin-specific CD4(+) T cells before TH2 sensitization was used to define T cell-specific TSLP effects. Atopic dermatitis and increased serum TSLP concentrations were induced by topical application of the vitamin D3 analog MC903. Memory cells in peripheral blood were monitored weekly with flow cytometry. Memory recall was tested after intranasal ovalbumin challenge. RESULTS: TSLP signaling in CD4(+) T cells is required for the generation/maintenance of memory cells after in vivo priming. TSLPR-deficient CD4(+) T cells have no defects in proliferation but do not survive 1 week after sensitization, and increased TSLP expression during sensitization significantly increased the frequency of memory cells. Although in vitro-differentiated TSLPR-deficient TH2 cells develop into memory cells with equal efficiency to wild-type cells, the recall response to airway antigen challenge is impaired. Moreover, after antigen challenge of mice with established TH2 memory, TSLP signaling in CD4(+) T cells significantly affects memory cell generation/maintenance from secondary effector cells. CONCLUSION: TSLP signaling in CD4(+) T cells is required for not only TH2 memory cell formation in vivo but also the recall response of the memory cells to local antigen challenge.
BACKGROUND:Thymic stromal lymphopoietin (TSLP) is a key factor in the development of allergic asthma. Numbers of TH2 memory cells gradually increase in allergicpatients with the progression of disease and persist in the lungs during remission, although the mechanism is not clear. OBJECTIVE: We sought to define the role of TSLP in TH2 memory cell generation and maintenance in vivo. METHODS: Adoptive transfer of wild-type and thymic stromal lymphopoietin receptor (TSLPR)-deficient ovalbumin-specific CD4(+) T cells before TH2 sensitization was used to define T cell-specific TSLP effects. Atopic dermatitis and increased serum TSLP concentrations were induced by topical application of the vitamin D3 analog MC903. Memory cells in peripheral blood were monitored weekly with flow cytometry. Memory recall was tested after intranasal ovalbumin challenge. RESULTS:TSLP signaling in CD4(+) T cells is required for the generation/maintenance of memory cells after in vivo priming. TSLPR-deficient CD4(+) T cells have no defects in proliferation but do not survive 1 week after sensitization, and increased TSLP expression during sensitization significantly increased the frequency of memory cells. Although in vitro-differentiated TSLPR-deficient TH2 cells develop into memory cells with equal efficiency to wild-type cells, the recall response to airway antigen challenge is impaired. Moreover, after antigen challenge of mice with established TH2 memory, TSLP signaling in CD4(+) T cells significantly affects memory cell generation/maintenance from secondary effector cells. CONCLUSION:TSLP signaling in CD4(+) T cells is required for not only TH2 memory cell formation in vivo but also the recall response of the memory cells to local antigen challenge.
Authors: Baohua Zhou; Michael R Comeau; Thibaut De Smedt; H Denny Liggitt; Martin E Dahl; David B Lewis; Dora Gyarmati; Theingi Aye; Daniel J Campbell; Steven F Ziegler Journal: Nat Immunol Date: 2005-09-04 Impact factor: 25.606
Authors: Mei Li; Pierre Hener; Zhikun Zhang; Shigeaki Kato; Daniel Metzger; Pierre Chambon Journal: Proc Natl Acad Sci U S A Date: 2006-07-31 Impact factor: 11.205
Authors: Jane Yoo; Miyuki Omori; Dora Gyarmati; Baohua Zhou; Theingi Aye; Avery Brewer; Michael R Comeau; Daniel J Campbell; Steven F Ziegler Journal: J Exp Med Date: 2005-08-15 Impact factor: 14.307
Authors: Mirjam Kool; Thomas Soullié; Menno van Nimwegen; Monique A M Willart; Femke Muskens; Steffen Jung; Henk C Hoogsteden; Hamida Hammad; Bart N Lambrecht Journal: J Exp Med Date: 2008-03-24 Impact factor: 14.307
Authors: Ian A Myles; Kelli W Williams; Jensen D Reckhow; Momodou L Jammeh; Nathan B Pincus; Inka Sastalla; Danial Saleem; Kelly D Stone; Sandip K Datta Journal: JCI Insight Date: 2016-07-07
Authors: Yrina Rochman; Krista Dienger-Stambaugh; Phoebe K Richgels; Ian P Lewkowich; Andrey V Kartashov; Artem Barski; Gurjit K Khurana Hershey; Warren J Leonard; Harinder Singh Journal: Sci Signal Date: 2018-03-13 Impact factor: 8.192
Authors: Ana P M Serezani; Gunseli Bozdogan; Sarita Sehra; Daniel Walsh; Purna Krishnamurthy; Elizabeth A Sierra Potchanant; Grzegorz Nalepa; Shreevrat Goenka; Matthew J Turner; Dan F Spandau; Mark H Kaplan Journal: J Allergy Clin Immunol Date: 2016-08-20 Impact factor: 10.793
Authors: Jee-Boong Lee; Chun-Yu Chen; Bo Liu; Luke Mugge; Pornpimon Angkasekwinai; Valeria Facchinetti; Chen Dong; Yong-Jun Liu; Marc E Rothenberg; Simon P Hogan; Fred D Finkelman; Yui-Hsi Wang Journal: J Allergy Clin Immunol Date: 2015-11-10 Impact factor: 10.793
Authors: Steven J Van Dyken; Jesse C Nussbaum; Jinwoo Lee; Ari B Molofsky; Hong-Erh Liang; Joshua L Pollack; Rachel E Gate; Genevieve E Haliburton; Chun J Ye; Alexander Marson; David J Erle; Richard M Locksley Journal: Nat Immunol Date: 2016-10-17 Impact factor: 25.606